{"organizations": [], "uuid": "e4fb6f2835bc5908483e3f335ceac05f183808bd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-seattle-genetics-says-if-deal-term/brief-seattle-genetics-says-if-deal-terminated-under-cascadian-therapeutics-to-pay-fee-of-17-million-idUSFWN1PQ0TI", "country": "US", "domain_rank": 408, "title": "BRIEF-Seattle Genetics Says If Deal Terminated Under, Cascadian Therapeutics To Pay Fee Of $17 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T14:25:00.000+02:00", "replies_count": 0, "uuid": "e4fb6f2835bc5908483e3f335ceac05f183808bd"}, "author": "", "url": "https://www.reuters.com/article/brief-seattle-genetics-says-if-deal-term/brief-seattle-genetics-says-if-deal-terminated-under-cascadian-therapeutics-to-pay-fee-of-17-million-idUSFWN1PQ0TI", "ord_in_thread": 0, "title": "BRIEF-Seattle Genetics Says If Deal Terminated Under, Cascadian Therapeutics To Pay Fee Of $17 Million", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-seattle genetics", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "seattle genetics inc", "sentiment": "none"}, {"name": "seattle genetics", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 26 PM / in 14 minutes BRIEF-Seattle Genetics Says If Deal Terminated Under, Cascadian Therapeutics To Pay Fee Of $17 Million   \nJan 31 (Reuters) - Seattle Genetics Inc: \n* SEATTLE GENETICS SAYS IF DEAL TERMINATED UNDER CERTAIN CIRCUMSTANCES, CASCADIAN THERAPEUTICS MAY BE REQUIRED TO PAY CO FEE OF $17 MILLION - SEC FILING Source text: ( bit.ly/2E2RNXK ) Further company coverage:", "external_links": [], "published": "2018-01-31T14:25:00.000+02:00", "crawled": "2018-01-31T14:47:10.030+02:00", "highlightTitle": ""}